| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a01cc761c501cf22665f7e2ae0ff2e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 |
| filingDate |
1973-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1975-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b7066263e7ba15df5c34e4fae9842ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6ccc046c7f969a5d8c846bb2afcb11a |
| publicationDate |
1975-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3888990-A |
| titleOfInvention |
Medicaments containing epicatechin-2-sulfonic acids and salts thereof |
| abstract |
A medicament against vascular diseases and conjunctive tissue disorders, comprising a pharmaceutically effective amount of (+)epicatechin-2-sulfonic acid, or (-)-epicatechin-2-sulfonic acid, or ( + OR - )-eipcatechin-2-sulfonic acid, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1501497-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1501497-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4906656-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8706128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4760088-A |
| priorityDate |
1970-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |